Even though sPD-L1 is a promising biomarker for many cancers, one should keep in mind that circulating sPD-L1 only reflects mPD-L1 that has been shed of from tumor cells and mature dendritic cells, while T cells and macrophages are refractory to shedding of PD-L1. This evidence concerns the gene SPDL1 and neoplasm.